287 related articles for article (PubMed ID: 32288859)
1. Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with CD30-positive lymphocyte-predominant (LP) cells.
Seliem RM; Ferry JA; Hasserjian RP; Harris NL; Zukerberg LR
J Hematop; 2011 Sep; 4(3):175. PubMed ID: 32288859
[TBL] [Abstract][Full Text] [Related]
2. CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center.
Menke JR; Spinner MA; Natkunam Y; Warnke RA; Advani RH; Gratzinger DA
Arch Pathol Lab Med; 2021 Jun; 145(6):753-758. PubMed ID: 32991677
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma.
Wang S; Medeiros LJ; Xu-Monette ZY; Zhang S; O'Malley DP; Orazi A; Zuo Z; Bueso-Ramos CE; Yin CC; Liu Z; Miranda RN; Young KH
Ann Diagn Pathol; 2014 Aug; 18(4):203-9. PubMed ID: 24852241
[TBL] [Abstract][Full Text] [Related]
4. EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults.
Huppmann AR; Nicolae A; Slack GW; Pittaluga S; Davies-Hill T; Ferry JA; Harris NL; Jaffe ES; Hasserjian RP
Am J Surg Pathol; 2014 Mar; 38(3):316-24. PubMed ID: 24525501
[TBL] [Abstract][Full Text] [Related]
5. Nodular Lymphocyte-predominant Hodgkin Lymphoma With Nodular Sclerosis: An Underrecognized Feature Associated With Pattern D.
El Hussein S; Wang X; Fang H; Jelloul FZ; Wang W; Loghavi S; Vega F; Miranda RN; Muzzafar T; Manning JT; Khoury JD; Burack WR; Evans AG; Medeiros LJ
Am J Surg Pathol; 2022 Sep; 46(9):1291-1297. PubMed ID: 35575765
[TBL] [Abstract][Full Text] [Related]
6. EBV-positive nodular lymphocyte predominant Hodgkin lymphoma: a single institution experience.
Fei F; Kiruthiga KG; Younes S; Natkunam Y
Hum Pathol; 2022 Nov; 129():32-39. PubMed ID: 35987347
[TBL] [Abstract][Full Text] [Related]
7. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
[TBL] [Abstract][Full Text] [Related]
8. Geographic Variability of Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Xia D; Sayed S; Moloo Z; Gakinya SM; Mutuiri A; Wawire J; Okiro P; Courville EL; Hasserjian RP; Sohani AR
Am J Clin Pathol; 2022 Feb; 157(2):231-243. PubMed ID: 34542569
[TBL] [Abstract][Full Text] [Related]
9. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting.
Fromm JR; Thomas A; Wood BL
Am J Pathol; 2017 Feb; 187(2):304-317. PubMed ID: 27998726
[TBL] [Abstract][Full Text] [Related]
10. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
11. Nodular lymphocyte-predominant Hodgkin lymphoma.
Savage KJ; Mottok A; Fanale M
Semin Hematol; 2016 Jul; 53(3):190-202. PubMed ID: 27496311
[TBL] [Abstract][Full Text] [Related]
12. Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma.
Song JY; Eberle FC; Xi L; Raffeld M; Rahma O; Wilson WH; Dunleavy K; Pittaluga S; Jaffe ES
Am J Surg Pathol; 2011 May; 35(5):767-72. PubMed ID: 21490448
[TBL] [Abstract][Full Text] [Related]
13. Intrafollicular classical Hodgkin lymphoma mimicking nodular lymphocyte predominant Hodgkin lymphoma: a report of two cases.
Tatsuno M; Maeshima AM; Kim SW; Maruyama D; Taniguchi H; Miyamoto K; Fukuhara S; Kobayashi Y; Tobinai K; Kushima R
Pathol Int; 2014 Dec; 64(12):613-7. PubMed ID: 25394195
[TBL] [Abstract][Full Text] [Related]
14. [Nodular lymphocyte-predominant Hodgkin lymphoma in children: clinical course, biology, and management].
Gorde-Grosjean S; Guimard G; Lambilliotte A; Coulomb-Lhermine A; Montravers F; Landman-Parker J
Bull Cancer; 2014 Sep; 101(9):881-90. PubMed ID: 25296072
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus infection patterns in nodular lymphocyte-predominant Hodgkin lymphoma.
Gerhard-Hartmann E; Jöhrens K; Schinagl LM; Zamó A; Rosenwald A; Anagnostopoulos I; Rosenfeldt M
Histopathology; 2022 Jun; 80(7):1071-1080. PubMed ID: 35322462
[TBL] [Abstract][Full Text] [Related]
16. Nodular lymphocyte predominant hodgkin lymphoma: biology, diagnosis and treatment.
Goel A; Fan W; Patel AA; Devabhaktuni M; Grossbard ML
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):261-70. PubMed ID: 24650975
[TBL] [Abstract][Full Text] [Related]
17. Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant.
Treetipsatit J; Metcalf RA; Warnke RA; Natkunam Y
Hum Pathol; 2015 Jan; 46(1):74-83. PubMed ID: 25456392
[TBL] [Abstract][Full Text] [Related]
18. T-Cell-Rich Hodgkin Lymphoma With Features of Classic Hodgkin Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Borderline Category With Overlapping Morphologic and Immunophenotypic Features.
El Hussein S; Fang H; Jelloul FZ; Wang W; Loghavi S; Miranda RN; Friedberg JW; Burack WR; Evans AG; Xu J; Medeiros LJ
Arch Pathol Lab Med; 2023 Dec; ():. PubMed ID: 38059511
[TBL] [Abstract][Full Text] [Related]
19. Immunoprofile of Hodgkin's lymphoma in India.
Patkar N; Mehta J; Kulkarni B; Pande R; Advani S; Borges A
Indian J Cancer; 2008; 45(2):59-63. PubMed ID: 18626150
[TBL] [Abstract][Full Text] [Related]
20. Biology, clinical course and management of nodular lymphocyte-predominant hodgkin lymphoma.
Nogová L; Rudiger T; Engert A
Hematology Am Soc Hematol Educ Program; 2006; ():266-72. PubMed ID: 17124071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
